Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Combination cancer immunotherapies: Emerging treatment strategies adapted to the tumor microenvironment
Nicole Kirchhammer, Marcel P. Trefny, Priska Auf der Maur, et al.
Science Translational Medicine (2022) Vol. 14, Iss. 670
Closed Access | Times Cited: 114

Showing 26-50 of 114 citing articles:

Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis
Xiangkun Wu, Hong Yan, Mingxing Qiu, et al.
eLife (2023) Vol. 12
Open Access | Times Cited: 14
Enhancing Cancer Chemo‐Immunotherapy: Innovative Approaches for Overcoming Immunosuppression by Functional Nanomaterials
Jingjing Wang, Li Li, Zhi Ping Xu
Small Methods (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 14
Role of tumor cell pyroptosis in anti-tumor immunotherapy
Lincheng Zhang, Haotian Bai, Jing Zhou, et al.
Cell Insight (2024) Vol. 3, Iss. 3, pp. 100153-100153
Open Access | Times Cited: 5
Targeting Dendritic Cell Dysfunction to Circumvent Anti-PD1 Resistance in Head and Neck Cancer
Shin Saito, Michihisa Kono, Hoang C.B. Nguyen, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 9, pp. 1934-1944
Open Access | Times Cited: 5
Metronomic chemotherapy plus anti-PD-1 in metastatic breast cancer: a Bayesian adaptive randomized phase 2 trial
Hongnan Mo, Yongpei Yu, Xiaoying Sun, et al.
Nature Medicine (2024) Vol. 30, Iss. 9, pp. 2528-2539
Closed Access | Times Cited: 5
Tumor-agnostic transcriptome-based classifier identifies spatial infiltration patterns of CD8+T cells in the tumor microenvironment and predicts clinical outcome in early-phase and late-phase clinical trials
Andreas Roller, Iakov I. Davydov, Petra Schwalie, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 4, pp. e008185-e008185
Open Access | Times Cited: 4
Focus on mechano-immunology: new direction in cancer treatment
Lin Zhao, Yajun Gui, Xiangying Deng
International Journal of Surgery (2025) Vol. 111, Iss. 3, pp. 2590-2602
Open Access
Mechanisms for resistance to BCMA-targeted immunotherapies in multiple myeloma
Tingting Yue, Yue Sun, Yun Dai, et al.
Blood Reviews (2025), pp. 101256-101256
Closed Access
Caerin 1.1/1.9-mediated antitumor immunity depends on IFNAR-Stat1 signalling of tumour infiltrating macrophage by autocrine IFNα and is enhanced by CD47 blockade
Junjie Li, Yuandong Luo, Quanlan Fu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
RNA methylation of CD47 mediates tumor immunosuppression in EGFR-TKI resistant NSCLC
Wei Zhang, Jiawen Wang, Jialu Liang, et al.
British Journal of Cancer (2025)
Closed Access
Photodynamic priming with red light triggers adaptive immune responses in a pancreatic cancer mouse model
Pushpamali De Silva, Mohammad A. Saad, Joseph W. R. Swain, et al.
Journal of Photochemistry and Photobiology B Biology (2025) Vol. 265, pp. 113126-113126
Closed Access
A Pyroptosis Radiosensitizer Facilitates Hypoxic Tumor Necrosis
Chenglu Gu, Dongmei Wang, Shuang Zhu, et al.
Small (2025)
Closed Access
Active microgel particle swarms for intrabronchial targeted delivery
Hui Chen, Junhui Law, Yibin Wang, et al.
Science Advances (2025) Vol. 11, Iss. 11
Closed Access
Applications of mRNA Delivery in Cancer Immunotherapy
Xiaoyu Pan, Yang-Wen-Qing Zhang, Caixia Dai, et al.
International Journal of Nanomedicine (2025) Vol. Volume 20, pp. 3339-3361
Open Access
Bifunctional Phagocytic Synapse Enhancers for Cancer Immunotherapy
Valerio Sabatino, Silvan Fleisch, Cong Tang, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2025)
Open Access
Unraveling the triad of immunotherapy, tumor microenvironment, and skeletal muscle biomechanics in oncology
Shuang Ma, Ying Lü, S.J. Sui, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
KRAS G12C-mutant driven non-small cell lung cancer (NSCLC)
R. Rosell, Jordi Codony‐Servat, Jessica González, et al.
Critical Reviews in Oncology/Hematology (2023) Vol. 195, pp. 104228-104228
Open Access | Times Cited: 12
Targeting ARID1A-Deficient Cancers: An Immune-Metabolic Perspective
Timofey Lebedev, Rubina Kousar, Bbumba Patrick, et al.
Cells (2023) Vol. 12, Iss. 6, pp. 952-952
Open Access | Times Cited: 11
Molecular mechanisms of osteosarcoma metastasis and possible treatment opportunities
Xinhui Du, Hua Wei, Boya Zhang, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 11
Aptamer‐Assisted Blockade of the Immune Suppressor Sialic Acid‐Binding Immunoglobulin‐Like Lectin‐15 for Cancer Immunotherapy
Qiuyue Wu, Xinyu Wei, Fude Chen, et al.
Angewandte Chemie International Edition (2023) Vol. 62, Iss. 52
Closed Access | Times Cited: 11
Extracellular Matrix‐Trapped Bioinspired Lipoprotein Prolongs Tumor Retention to Potentiate Antitumor Immunity
Yao Wu, Yongping Li, Zixin Hu, et al.
Advanced Materials (2024) Vol. 36, Iss. 15
Closed Access | Times Cited: 4
The significance of targeting lysosomes in cancer immunotherapy
Yanxin Xu, Bo Shao, Yafeng Zhang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Synergizing CXCL9 with BRD4‐PROTAC Using Nanochaperone Boosts Robust T Cell‐Dependent Antitumor Immune Responses for Cancer Immunotherapy
Jiajing Chen, Feihe Ma, Yongxin Zhang, et al.
Advanced Functional Materials (2024) Vol. 34, Iss. 23
Closed Access | Times Cited: 4
Overcoming Resistance to Immune Checkpoint Blockade in Liver Cancer with Combination Therapy: Stronger Together?
Wiebke Werner, Maria Kuzminskaya, Isabella Lurje, et al.
Seminars in Liver Disease (2024) Vol. 44, Iss. 02, pp. 159-179
Open Access | Times Cited: 4
Comprehensive analysis of mitochondrial-related gene signature for prognosis, tumor immune microenvironment evaluation, and candidate drug development in colon cancer
Hao Wu, Wentao Zhang, Jingjia Chang, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access

Scroll to top